Health Care • Medical/Dental Instruments
$0.77 ▲ +0.01
(+0.69%)
MKT CAP: $466.9K • VOL: 191.1K
52W L $1 52W H $1,725
ROARABLE / RQD
D+ • 52/100
PIOTROSKI
1 / 9
PFSA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $100.0K | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$27.7M | -$4.5M | -$1.5M |
| Operating Margin % | — | -80.0% | — |
| Net Income (GAAP) | -$35.8M | -$9.2M | $1.2M |
| EBITDA (Normalized) | -$27.7M | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$16.2M | -$2.1M | -$2.1M |
| Capital Expenditures (CapEx) | $8.0K | — | — |
| Free Cash Flow (FCF) | -$16.3M | -$2.1M | -$2.1M |
| FCF Margin % | — | -80.0% | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $1.8M | $191.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$26.7M | -$119.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PFSA.